SPRY - ARS Pharmaceuticals, Inc. Quarterly EPS earnings growth
The ARS Pharmaceuticals (SPRY) team brings together top specialists in bringing original drugs to market. Historical quarterly EPS growth clearly demonstrates profit dynamics, where the current level of the metric is 30.80. The company focuses on creating Neffy, a needle-free spray for treating anaphylaxis. Currently, the business is spending its accumulated funds, as product commercialization costs exceed current revenues.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_SPRY_-_ARS-Pharmaceuticals_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "ars-pharma.com (SPRY): Year-over-year earnings per share growth for the last twelve months from 04/28/2023 to 11/12/2026 | 👁️GURU.Markets👁️")
ARS Corp (SPRY) - metric breakdowns and financial figures
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Debt to Equity ARS Pharmaceuticals|SPRY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity ARS Pharmaceuticals|SPRY - Company Total Debt Obligations|Debt to Book Value ARS Pharma|SPRY - Company Long-Term Loans and Borrowings|Company Short-Term Debt ARS Pharmaceuticals|Quick Ratio ars-pharma.com
- earnings and market multiples details:
SPRY - Final Profit|Projected Future Earnings ARS Pharmaceuticals|SPRY - P/E Multiple|Future Price to Earnings ARS Pharma|SPRY - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ARS Pharma|SPRY - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) ARS Pharmaceuticals|SPRY - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth ars-pharma.com|SPRY - Net earnings per share growth this year|Earnings growth forecast for next year ARS Pharmaceuticals
Analysis of all company metrics:ARS Pharmaceuticals, Inc., SPRY
In the biotechnology sector, profit dynamics determine the transition stage from research and development to commercialization. This quarterly earnings per share growth measures the percentage change in net income per common share relative to the previous period. A positive trend in this indicator confirms the effectiveness of innovation monetization. For ARS Pharmaceuticals (SPRY), this growth will serve as a key marker for the successful market launch of the neffy spray. A steady increase in EPS will confirm the fundamental stability of the business model.
Who ARS Pharmaceuticals competes with
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|Quarterly EPS earnings growth Alvotech S.A. ALVO|LQDA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months GLPG (Galapagos Corp)|ANI Pharmaceuticals (ANIP) - Year-over-year earnings per share growth for the last twelve months|MNKD - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AMPH|PCRX: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Theravance (TBPH)|AQST: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth SCPH (scPharmaceuticals)|Year-over-year earnings per one share growth for the last 12 months TECX|Tonix Pharmaceuticals Holding Corp. - Quarterly EPS earnings growth|SXTC - Quarterly EPS earnings growth|eupraxiapharma.com (EPRX) - Year-over-year earnings per share growth for the last twelve months|BioHarvest Sciences Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months eXoZymes Inc|Year-over-year net earnings per share growth for the last 12 months Oramed Pharma (ORMP)|Quarterly EPS earnings growth ENTX|Quarterly EPS earnings growth MindWalk Holdings, Inc. (HYFT)|Quarterly EPS earnings growth ABVC (ABVC BioPharma Inc)|CPIX - Year-over-year net earnings per share growth for the last 12 months|Quantum BioPharma Ltd - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months fibrogen.com|TELO (Telomir Pharmaceuticals, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Rani Therapeutics Holdings, Inc. (RANI) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months SNYR|RLYB (Rallybio Corp.) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth LEXX|Year-over-year net earnings per share change for the last twelve months pulmatrix.com|Quarterly EPS earnings growth PTHL (Pheton Holdings)|APM - Year-over-year net earnings per share growth for the last 12 months|Lyra Therapeutics, Inc - Quarterly EPS earnings growth|IBO - Quarterly EPS earnings growth|tnfpharma.com (TNFA) - Year-over-year earnings per share growth for the last twelve months|YCBD (cbdMD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months PainReform|Auris Medical (CYTO) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Lipella (LIPO)|Year-over-year net earnings per share change for the last twelve months OptiNose Corp|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals PIRS|PROC (procapsgroup.com) - Year-over-year net earnings per share trend for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months QLI (Qilian International Holding Group)|SLRN (ACELYRIN, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months TFF Pharmaceuticals, Inc (TFFP)
